REG - Wells Fargo & Co - Doc re. Schedule 14A
RNS Number : 0408VWells Fargo & Company03 April 2019Publication of Definitive Proxy Statement for Wells Fargo & Company
On 2 April 2019, Wells Fargo & Company filed with the U.S. Securities and Exchange Commission its definitive Supplement to Proxy Statement for its 2019 Annual Meeting of Stockholders.
Copies of this document can be downloaded via the following link:
http://www.rns-pdf.londonstockexchange.com/rns/0408V_1-2019-4-3.pdf
For further information, please contact:
Media:
Ancel Martinez
+1 415-222-3858
Investors:
John M. Campbell
+1 415-396-0523
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDDOCBSGDSIUGBGCX
Recent news on Wells Fargo & Co
See all newsREG - Wells Fargo Finance - Publication of Listing Supplement
AnnouncementREG - Wells Fargo & Co - Doc re. 8-K
AnnouncementREG - Wells Fargo Finance - Publication of Listing Supplement
AnnouncementREG - Stock Exch Notice - Admission to ISM - 29/01/2026
AnnouncementREG - Wells Fargo & Co - Publication of Final Terms
Announcement